ADMA
Price
$16.43
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
ITOS
Price
$8.93
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

ADMA vs ITOS

Header iconADMA vs ITOS Comparison
Open Charts ADMA vs ITOSBanner chart's image
ADMA Biologics
Price$16.43
Change-$0.00 (-0.00%)
Volume$2.73M
CapitalizationN/A
iTeos Therapeutics
Price$8.93
Change-$0.00 (-0.00%)
Volume$400.33K
CapitalizationN/A
View a ticker or compare two or three
ADMA vs ITOS Comparison Chart
Loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ADMA vs. ITOS commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a Buy and ITOS is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ADMA: $16.43 vs. ITOS: $8.93)
Brand notoriety: ADMA and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 48% vs. ITOS: 50%
Market capitalization -- ADMA: $4.66B vs. ITOS: $383.48M
ADMA [@Biotechnology] is valued at $4.66B. ITOS’s [@Biotechnology] market capitalization is $383.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 1 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • ADMA’s FA Score: 1 green, 4 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ADMA is a better buy in the long-term than ITOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 6 TA indicator(s) are bullish while ITOS’s TA Score has 4 bullish TA indicator(s).

  • ADMA’s TA Score: 6 bullish, 4 bearish.
  • ITOS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ADMA is a better buy in the short-term than ITOS.

Price Growth

ADMA (@Biotechnology) experienced а +5.19% price change this week, while ITOS (@Biotechnology) price change was -1.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ADMA is expected to report earnings on Mar 20, 2025.

ITOS is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.66B) has a higher market cap than ITOS($383M). ADMA YTD gains are higher at: 263.496 vs. ITOS (-18.447). ADMA has higher annual earnings (EBITDA): 67.7M vs. ITOS (-136.64M). ITOS has more cash in the bank: 571M vs. ADMA (88.2M). ITOS has less debt than ADMA: ITOS (5.52M) vs ADMA (141M). ADMA has higher revenues than ITOS: ADMA (330M) vs ITOS (35M).
ADMAITOSADMA / ITOS
Capitalization4.66B383M1,217%
EBITDA67.7M-136.64M-50%
Gain YTD263.496-18.447-1,428%
P/E Ratio142.86N/A-
Revenue330M35M943%
Total Cash88.2M571M15%
Total Debt141M5.52M2,556%
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
9
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
41
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADMAITOS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 6 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with ATRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
+3.92%
ATRA - ADMA
44%
Loosely correlated
+2.67%
NVAX - ADMA
39%
Loosely correlated
+5.18%
RCUS - ADMA
38%
Loosely correlated
+2.08%
ITOS - ADMA
38%
Loosely correlated
+2.41%
IMTX - ADMA
37%
Loosely correlated
+0.22%
More

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with IBO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+2.41%
IBO - ITOS
43%
Loosely correlated
-4.31%
RCUS - ITOS
42%
Loosely correlated
+2.08%
BMRN - ITOS
41%
Loosely correlated
+0.59%
NVAX - ITOS
39%
Loosely correlated
+5.18%
STRO - ITOS
38%
Loosely correlated
+3.77%
More